✦ LIBER ✦

Reduced release of tissue factor by application of a centrifugal pump during cardiopulmonary bypass

✍ Scribed by J. Babin-Ebell; M. Misoph; W. Müllges; K. Neukam; O. Elert

Book ID: 105297743
Publisher: Springer
Year: 1998
Tongue: English
Weight: 466 KB
Volume: 13
Category: Article
ISSN: 0910-8327
DOI: 10.1007/bf01747832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of tissue factor pathway inh

Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass

✍ B. S. DONAHUE; D. GAILANI; A. E. MAST 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Matrix metalloproteinase-9, tissue inhib

Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor α release during cardiopulmonary bypass

✍ H. F. Galley; G. D. Macaulay; N. R. Webster 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

**Summary** An inflammatory response occurs during cardiac surgery involving cardiopulmonary bypass. Matrix metalloproteinase‐9 is an enzyme involved in cytokine processing and leucocyte extravasation. It is secreted as a pro‐enzyme in response to several inflammatory mediators and is inhibited by e

Clinical Effectiveness of Centrifugal Pu

Clinical Effectiveness of Centrifugal Pump to Produce Pulsatile Flow During Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery

✍ Y. John Gu; Willem van Oeveren; Hubert E. Mungroop; Anne H. Epema; Inez J. den H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB